Abstract
Seizure disorder is the third most common neurological disorder in the elderly after stroke and dementia. With the increasing geriatric population, the situation of clinicians seeing more and more elderly epilepsy patients is very likely. Not only is the diagnosis of epilepsy tedious in the elderly, its management raises many challenging issues for the treating physicians. Altered physiology, age-related decline in organ function, and plasma protein binding and altered pharmacodynamics make the elderly patients with seizure disorder a difficult group to treat. This is further complicated by the presence of comorbidities and polypharmacy which increase the chances of drug interactions. The adverse effects that might be tolerated well in younger populations may be disastrous for the aged. Although the newer antiepileptic drugs are found to have a favorable safety profile, there is relative scarcity of randomized-controlled trials involving older and newer antiepileptics in the geriatric population. This review tries to compile the available literature on management of epilepsy in the elderly population including evidence of safety and efficacy of newer and older antiepileptics with special reference to the ‘geriatric giants’. It also deals with the interactions between antiepileptic medications and other commonly prescribed drugs in the elderly such as anti-hypertensives and antiischemic agents. The recommended guidelines of various international bodies are also analyzed from the perspective of elderly with seizure disorder.
Similar content being viewed by others
References
Chen LA, Cheng SJ, Jou SB (2012) Epilepsy in the elderly. Int J Gerontol 6(2):63–67
Acharya JN, Acharya VJ (2014) Epilepsy in the elderly: special considerations and challenges. Ann Indian Acad Neurol 17(Suppl 1):S18–S26
Pugh MJV, Van Cott AC, Cramer JA, Knoefel JE, Amuan ME, Tabares J et al (2008) Trends in antiepileptic drug prescribing for older patients with new-onset epilepsy: 2000–2004. Neurology 70(22 Pt 2):2171–2178
de Assis TR, Nascimento OJM, Costa G, Bacellar A (2014) Antiepileptic drugs patterns in elderly inpatients in a Brazilian tertiary center, Salvador, Brazil TT—uso de drogas antiepilépticas em idosos internados em centro terciário, Salvador, Brasil. Arq Neuropsiquiatr 72(11):874–880
Bruun E, Virta LJ, Kälviäinen R, Keränen T (2015) Choice of the first anti-epileptic drug in elderly patients with newly diagnosed epilepsy: a Finnish retrospective study. Seizure 31:27–32
Higashida K, Tanaka T, Yamagami H, Tomari S, Fukuma K, Okuno Y et al (2018) A nationwide multi-center questionnaire survey on the management and treatment of post-stroke seizure and epilepsy in Japan. Rinsho Shinkeigaku 58(4):217–222
Bathena SPR, Leppik IE, Kanner AM, Birnbaum AK (2017) Antiseizure, antidepressant, and antipsychotic medication prescribing in elderly nursing home residents. Epilepsy Behav 69:116–120
Theitler J, Brik A, Shaniv D, Berkovitch M, Gandelman-Marton R (2017) Antiepileptic drug treatment in community-dwelling older patients with epilepsy: a retrospective observational study of old- versus new-generation antiepileptic drugs. Drugs Aging 34(6):479–487
Huber DP, Griener R, Trinka E (2013) Antiepileptic drug use in Austrian nursing home residents. Seizure 22(1):24–27
Zhuo C, Jiang R, Li G, Shao M, Chen C, Chen G et al (2017) Efficacy and tolerability of second and third generation anti-epileptic drugs in refractory epilepsy: a network meta-analysis. Sci Rep 7(1):1–12
Pohlmann-Eden B, Marson AG, Noack-Rink M, Ramirez F, Tofighy A, Werhahn KJ et al (2016) Comparative effectiveness of levetiracetam, valproate and carbamazepine among elderly patients with newly diagnosed epilepsy: subgroup analysis of the randomized, unblinded KOMET study. BMC Neurol 16(1):149
Arif H, Buchsbaum R, Pierro J, Whalen M, Sims J, Resor SR Jr et al (2010) Comparative effectiveness of 10 antiepileptic drugs in older adults with epilepsy. Arch Neurol 67(4):408–415
Werhahn KJ, Trinka E, Dobesberger J, Unterberger I, Baum P, Deckert-Schmitz M et al (2015) A randomized, double-blind comparison of antiepileptic drug treatment in the elderly with new-onset focal epilepsy. Epilepsia 56(3):450–459
Werhahn KJ, Klimpe S, Balkaya S, Trinka E, Krämer G (2011) The safety and efficacy of add-on levetiracetam in elderly patients with focal epilepsy: a one-year observational study. Seizure 20(4):305–311
Rowan AJ, Ramsay RE, Collins JF, Pryor F, Boardman KD, Uthman BM et al (2005) New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine. Neurology 64(11):1868–1873
Rambeck B, Wolf P (1993) Lamotrigine clinical pharmacokinetics. Clin Pharmacokinet 25(6):433–443
Bockbrader HN, Wesche D, Miller R, Chapel S, Janiczek N, Burger P (2010) A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin. Clin Pharmacokinet 49(10):661–669
Bialer M, Doose DR, Murthy B, Curtin C, Wang S-S, Twyman RE et al (2004) Pharmacokinetic interactions of topiramate. Clin Pharmacokinet 43(12):763–780
Patsalos PN (2004) Clinical pharmacokinetics of levetiracetam. Clin Pharmacokinet 43(11):707–724
Barcs G, Walker EB, Elger CE, Scaramelli A, Stefan H, Sturm Y et al (2000) Oxcarbazepine placebo-controlled, dose-ranging trial in refractory partial epilepsy. Epilepsia 41(12):1597–1607
May TW, Korn-Merker E, Rambeck B (2003) Clinical pharmacokinetics of oxcarbazepine. Clin Pharmacokinet 42(12):1023–1042
Johannessen SI, Landmark CJ (2010) Antiepileptic drug interactions—principles and clinical implications. Curr Neuropharmacol 8(3):254–267
Theis JGW, Sidhu J, Palmer J, Job S, Bullman J, Ascher J (2005) Lack of pharmacokinetic interaction between oxcarbazepine and lamotrigine. Neuropsychopharmacology 30(12):2269–2274
Bourgeois BF (1996) Drug interaction profile of topiramate. Epilepsia 37(Suppl 2):S14–S17
Johannessen Landmark C, Patsalos PN (2010) Drug interactions involving the new second- and third-generation antiepileptic drugs. Expert Rev Neurother 10(1):119–140
Heiskanen T, Kalso E (2012) Non-analgesic effects of opioids: interactions between opioids and other drugs. Curr Pharm Des 18(37):6079–6089
Ruiz-Giménez J, Sánchez-Alvarez JC, Cañadillas-Hidalgo F, Serrano-Castro PJ, Andalusian Epilepsy Society (2010) Antiepileptic treatment in patients with epilepsy and other comorbidities. Seizure 19(7):375–382
Jankovic SM, Dostic M (2012) Choice of antiepileptic drugs for the elderly: possible drug interactions and adverse effects. Expert Opin Drug Metab Toxicol 8(1):81–91
Bialer M, Soares-da-Silva P (2012) Pharmacokinetics and drug interactions of eslicarbazepine acetate. Epilepsia 53(6):935–946
Leppik IE (2004) Zonisamide: chemistry, mechanism of action, and pharmacokinetics. Seizure 13(Suppl 1):S5–S9 (discussion S10)
Flesch G (2004) Overview of the clinical pharmacokinetics of oxcarbazepine. Clin Drug Investig 24(4):185–203
Sills G, Brodie M (2007) Pharmacokinetics and drug interactions with zonisamide. Epilepsia 48(3):435–441
Glauser T, Ben-Menachem E, Bourgeois B, Cnaan A, Guerreiro C, Kälviäinen R et al (2013) Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 54(3):551–563
https://www.nice.org.uk/guidance/cg137/chapter/1-Guidance#older-people-with-epilepsy
Kanner AM, Ashman E, Gloss D, Harden C, Bourgeois B, Bautista JF et al (2018) Practice guideline update summary: efficacy and tolerability of the new antiepileptic drugs I: treatment of new-onset epilepsy. Neurology 91(2):74–81
Eddy CM, Rickards HE, Cavanna AE (2011) The cognitive impact of antiepileptic drugs. Ther Adv Neurol Disord 4(6):385–407
Fritz N, Glogau S, Hoffmann J, Rademacher M, Elger CE, Helmstaedter C (2005) Efficacy and cognitive side effects of tiagabine and topiramate in patients with epilepsy. Epilepsy Behav 6(3):373–381
Lippa CF, Rosso A, Hepler M, Jenssen S, Pillai J, Irwin D (2010) Levetiracetam: a practical option for seizure management in elderly patients with cognitive impairment. Am J Alzheimers Dis Other Demen 25(2):149–154
Ishizue N, Niwano S, Saito M, Fukaya H, Nakamura H, Igarashi T et al (2016) Polytherapy with sodium channel-blocking antiepileptic drugs is associated with arrhythmogenic ST-T abnormality in patients with epilepsy. Seizure 40:81–87
Guldiken B, Rémi J, Noachtar S (2016) Cardiovascular adverse effects of phenytoin. J Neurol 263(5):861–870
Saetre E, Abdelnoor M, Amlie JP, Tossebro M, Perucca E, Taubøll E et al (2009) Cardiac function and antiepileptic drug treatment in the elderly: a comparison between lamotrigine and sustained-release carbamazepine. Epilepsia 50(8):1841–1849
Can İ, Tholakanahalli V (2016) Carbamazepine-induced atrioventricular block in an elderly woman. Turk Kardiyol Dern Ars 44(1):68–70
Svalheim S, Luef G, Rauchenzauner M, Mørkrid L, Gjerstad L, Taubøll E (2010) Cardiovascular risk factors in epilepsy patients taking levetiracetam, carbamazepine or lamotrigine. Acta Neurol Scand Suppl 190:30–33
Kim DW, Lee S-Y, Shon Y-M, Kim JH (2013) Effects of new antiepileptic drugs on circulatory markers for vascular risk in patients with newly diagnosed epilepsy. Epilepsia 54(10):e146–e149
Mintzer S, Skidmore CT, Abidin CJ, Morales MC, Chervoneva I, Capuzzi DM et al (2009) Effects of antiepileptic drugs on lipids, homocysteine, and C-reactive protein. Ann Neurol 65(4):448–456
Ley M, Principe A, Jiménez-Conde J, Rocamora R (2015) Assessing long-term effects of eslicarbazepine acetate on lipid metabolism profile, sodium values and liver function tests. Epilepsy Res 115:147–152
Katsiki N, Mikhailidis DP, Nair DR (2014) The effects of antiepileptic drugs on vascular risk factors: a narrative review. Seizure 23(9):677–684
Petty SJ, O’Brien TJ, Wark JD (2007) Anti-epileptic medication and bone health. Osteoporos Int 18(2):129–142
Jetté N, Lix LM, Metge CJ, Prior HJ, McChesney J, Leslie WD (2011) Association of antiepileptic drugs with nontraumatic fractures: a population-based analysis. Arch Neurol 68(1):107–112
Mikati MA, Dib L, Yamout B, Sawaya R, Rahi AC, Fuleihan GEH (2006) Two randomized vitamin D trials in ambulatory patients on anticonvulsants: impact on bone. Neurology 67(11):2005–2014
Berghuis B, de Haan G-J, van den Broek MPH, Sander JW, Lindhout D, Koeleman BPC (2016) Epidemiology, pathophysiology and putative genetic basis of carbamazepine- and oxcarbazepine-induced hyponatremia. Eur J Neurol 23(9):1393–1399
Kibar S, Demir S, Sezer N, Köseoğlu BF, Dalyan Aras M, Kesikburun B (2015) Gabapentin-induced urinary incontinence: a rare side effect in patients with neuropathic pain. Case Rep Neurol Med 2015:1–3
Jafferany M, Shireen F, Ibrahim A (2010) Lamotrigine-induced vaginitis and dysuria in an adult woman with bipolar depression. Prim Care Companion J Clin Psychiatry 12:3
Malik AM, Usmani A (2013) Day time urinary incontinence due to valproate in a patient with idiopathic generalized tonic clonic seizures. J Case Rep 3(1):53–55
Gandhi S, McArthur E, Mamdani MM, Hackam DG, McLachlan RS, Weir MA et al (2016) Antiepileptic drugs and hyponatremia in older adults: two population-based cohort studies. Epilepsia 57(12):2067–2079
Berghuis B, van der Palen J, de Haan G-J, Lindhout D, Koeleman BPC, Sander JW et al (2017) Carbamazepine- and oxcarbazepine-induced hyponatremia in people with epilepsy. Epilepsia 58(7):1227–1233
Nasrallah K, Silver B (2005) Hyponatremia associated with repeated use of levetiracetam. Epilepsia 46(6):972–973
Schoenberg MR, Rum RS, Osborn KE, Werz MA (2017) A randomized, double-blind, placebo-controlled crossover study of the effects of levetiracetam on cognition, mood, and balance in healthy older adults. Epilepsia 58(9):1566–1574
Mazza M, Martini A, Scoppetta M, Mazza S (2008) Effect of levetiracetam on depression and anxiety in adult epileptic patients. Prog Neuropsychopharmacol Biol Psychiatry 32(2):539–543
Pugh MJV, Copeland LA, Zeber JE, Wang C-P, Amuan ME, Mortensen EM et al (2012) Antiepileptic drug monotherapy exposure and suicide-related behavior in older veterans. J Am Geriatr Soc 60(11):2042–2047
Kalinin VV (2007) Suicidality and antiepileptic drugs: is there a link? Drug Saf 30(2):123–142
Pinheiro D (2008) Anticonvulsant mood stabilizers in the treatment of behavioral and psychological symptoms of dementia (BPSD). Encephale 34(4):409–415
Sommer OH, Aga O, Cvancarova M, Olsen IC, Selbaek G, Engedal K (2009) Effect of oxcarbazepine in the treatment of agitation and aggression in severe dementia. Dement Geriatr Cogn Disord 27(2):155–163
Gilad R (2012) Management of seizures following a stroke: what are the options? Drugs Aging 29(7):533–538
Goldstein LB (1995) Common drugs may influence motor recovery after stroke. The Sygen In Acute Stroke Study Investigators. Neurology 45(5):865–871
Verrotti A, Manco R, Matricardi S, Franzoni E, Chiarelli F (2007) Antiepileptic drugs and visual function. Pediatr Neurol 36(6):353–360
Stefan H, Bernatik J, Knorr J (1999) Visual field defects due to antiepileptic drugs. Nervenarzt 70(6):552–555
Hmouda H, Ben Salem C, Grira M, Slim R, Bouraoui K (2007) Carbamazepine-induced urinary retention. Br J Clin Pharmacol 64(6):833–834
Bar S, Feller N, Savir H (1983) Presenile cataracts in phenytoin-treated epileptic patients. Arch Ophthalmol (Chicago, Ill 1960) 101(3):422–425
Villanueva V, Giráldez BG, Toledo M, De Haan GJ, Cumbo E, Gambardella A et al (2018) Lacosamide monotherapy in clinical practice: a retrospective chart review. Acta Neurol Scand 138(3):186–194
Rohracher A, Zimmermann G, Villanueva V, Garamendi I, Sander JW, Wehner T et al (2018) Perampanel in routine clinical use across Europe: pooled, multicenter, observational data. Epilepsia 59(9):1727–1739
Leppik IE, Wechsler RT, Williams B, Yang H, Zhou S, Laurenza A (2015) Efficacy and safety of perampanel in the subgroup of elderly patients included in the phase III epilepsy clinical trials. Epilepsy Res 110:216–220
Brodie MJ, Whitesides J, Schiemann J, D’Souza J, Johnson ME (2016) Tolerability, safety, and efficacy of adjunctive brivaracetam for focal seizures in older patients: a pooled analysis from three phase III studies. Epilepsy Res 127:114–118
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Dr. Chakrabarti received honoraria from Novartis and Intas Pharmaceuticals. None of the other authors report any conflict of interest.
Informed consent/ethical approval
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Kaur, U., Chauhan, I., Gambhir, I.S. et al. Antiepileptic drug therapy in the elderly: a clinical pharmacological review. Acta Neurol Belg 119, 163–173 (2019). https://doi.org/10.1007/s13760-019-01132-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13760-019-01132-4